<DOC>
	<DOC>NCT01595724</DOC>
	<brief_summary>The study aims to collect data on the influence of a treatment with Visanne (Dienogest 2mg/d) on the Endometriosis related quality of life. These data will be collected using a special patient questionnaire (Endometriosis Health Profile 5, EHP-5). The study will also be used to describe the basic disease status and demographic characteristics of patients searching treatment by a gynecologist because of their endometriosis. In addition, the study will give insight into the typical diagnostic measures the physicians in different countries are using in the field of endometriosis.</brief_summary>
	<brief_title>Daily Practice Treatment and Influence of Visanne on the Patient Assessment of Quality of Life</brief_title>
	<detailed_description />
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Dienogest</mesh_term>
	<criteria>Female patients older than 18 years of age Clinical or laparoscopic diagnosis of endometriosis Having endometriosis related pain as leading symptom Decision taken by physician to prescribe Visanne Signed Informed Consent Form Contraindications listed in the local summary of product characteristics (SPC) have to be considered.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Non-interventional study</keyword>
	<keyword>Endometriosis,</keyword>
	<keyword>Quality of life</keyword>
</DOC>